Hypermethioninemia due to S-adenosylhomocysteine hydrolase deficiency
Alternate names[edit | edit source]
Psychomotor delay due to S-adenosylhomocysteine hydrolase deficiency; Psychomotor retardation due to S-adenosylhomocysteine hydrolase deficiency; Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase
Definition[edit | edit source]
Hypermethioninemia due to S-adenosylhomocysteine hydrolase deficiency (SAHH deficiency) is a muscle disease associated with high blood levels of methionine and creatine kinase (CK).
Cause[edit | edit source]
SAHH deficiency is caused by mutations in the AHCY gene.
Inheritance[edit | edit source]
Inheritance is autosomal recessive.
Signs and symptoms[edit | edit source]
Very few patients have being reported with this disease. SAHH patients may not have any symptoms. The observed signs and symptoms in the reported patients included:
- Muscle disease (myopathy) with a blood exam showing an increase of the CK activity (in 100% of the reported cases)
- Hypotonia
- Developmental delay
- Behavioral disorders
- Very small head (microcephaly)
- Myelination delay
- Strabismus
- Problems with blood coagulation
- Liver disease
- Two sisters had fetal hydrops, brain anomalies and respiratory failure and death in early infancy. Also, a recent report described a 29 year old woman who had liver cancer.
Diagnosis[edit | edit source]
Molecular Genetics Tests may include:
- Deletion/duplication analysis
- Sequence analysis of the entire coding region
- Targeted variant analysis
- Sequence analysis of select exons
Treatment[edit | edit source]
Because this disease affects many organs and may begin before birth, it may be difficult to treat. It is possible that blood abnormalities are present in all patients in utero. Treatment may include: A low methionine diet: This can decrease and sometimes even normalize the abnormalities in the blood exams.
- Patients have to be on a protein restricted diet and supplemented with a methionine-free amino acid mixture.
Supplementation with phosphatidylcholine and creatine: At this time there is no evidence that this treatment is effective. Liver transplantation: Recently, liver transplantation was successfully done in one girl at the age of 40 months, but longer follow-up is needed to know the outcome of the liver transplantation.
- The treatment outcome depends on the severity of the disease.
- It is not known whether even early intervention could help in severe cases.
- In others, it is possible that earlier initiation of treatment may improve the outcome.
- Regular careful evaluation of all body systems is indicated, mainly of the nervous system, psychomotor development, muscles, liver and blood (for coagulation).
- This includes imaging studies, especially regular liver imaging and blood exams.
NIH genetic and rare disease info[edit source]
Hypermethioninemia due to S-adenosylhomocysteine hydrolase deficiency is a rare disease.
Hypermethioninemia due to S-adenosylhomocysteine hydrolase deficiency Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Deepika vegiraju